FDA Adverse Event Malfunction Summary report: N

PIPELINE EMBOLIZATION DEVICE

MDR report key: 3820170 · Received May 20, 2014

Report

Report Number
2029214-2014-00292
Event Type
Malfunction
Date Received
May 20, 2014
Date of Event
May 5, 2014
Report Date
May 5, 2014
Manufacturer
EV3 NEUROVASCULAR
Product Code
OUT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE INVOLVED IN THE EVENT WILL NOT BE RETURNED FOR EVALUATION AS IT WAS LOST AFTER THE PROCEDURE. (B)(4).

Description of Event or Problem · 1

TREATMENT OF A SMALL AMORPHOUS ANEURYSM MEASURING 7.8MM X 7MM. THE PATIENT HAD A HEMORRHAGIC STROKE ONE WEEK PRIOR TO THE PIPELINE PROCEDURE AND WAS WEAK IN THE LEFT ARM. THE PATIENT WAS GIVEN DUAL-ANTIPLATELET THERAPY. ON 05 MAY 2014, THE PATIENT UNDERWENT PIPELINE EMBOLIZATION TREATMENT. DURING THE PROCEDURE, IT WAS REPORTED THE FIRST PIPELINE (5MM X 18MM) DID NOT OPEN PROXIMALLY AND HAD TO BE REMOVED WITH A SNARE. THE SECOND PIPELINE (5MM X 20MM) ALSO DID NOT OPEN AND WAS REMOVED BY TRAPPING THE PIPELINE BETWEEN THE CAPTURE COIL AND CATHETER. THE THIRD DEVICE (5MM X 20MM) WAS IMPLANTED AND DID NOT OPEN AT FIRST, BUT EVENTUALLY OPENED WITH THE HELP OF A SEPTORIA BALLOON THAT WAS ADVANCED THROUGH THE P-COMM (POSTERIOR COMMUNICATING ARTERY) IN ORDER TO ANGIOPLASTY (AN OPTION PRESENTED IN THE INSTRUCTIONS FOR USE, U.S.) THE PIPELINE OPEN. THE PATIENT WAS VERY SLOW TO WAKE UP AND SHE ALSO EXPERIENCED MILD APHASIA POST PROCEDURE THAT RESOLVED OVER A FEW DAYS. THE PHYSICIAN BELIEVED THESE EVENTS MAY HAVE BEEN DUE TO THE PREVIOUS STROKE COMBINED WITH A LONG TIME UNDER ANESTHESIA. THE PATIENT WAS ON ASPIRIN AND PLAVIX AND WAS DOING FINE. SAME EVENT AS MDR# 2029214-2014-00291 AND 2029214-2014-00293.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
299160 PIPELINE EMBOLIZATION DEVICE FLOW DIVERSION OUT EV3 NEUROVASCULAR FA-77500-20 9771464

Patients

Seq Age Sex Outcome Treatment
1 65 YR